Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+89.1%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+89.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
6.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$521.31M+54.7%
2024$336.89M+80.8%
2023$186.37M+141.8%
2022$77.06M+302.7%
2021$19.14M-
2020$0.00-
2019$0.00-
2018$0.00-